Physician profile
Lisa C Hendricks
NPI 1932170263
$13,071.36
in general payments reported to CMS, 2019-2025
29 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $73.04 · 2021: $568 · 2022: $180 · 2023: $317 · 2024: $286 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $885 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,183.99 |
| Food and Beverage | $884.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,717.32 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $697.44 | 2019-2025 | |
| Astellas Pharma US INC | $341.12 | 2022-2025 | Veozah |
| Sumitomo Pharma America, INC. | $306.78 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $121.23 | 2019-2024 | Gardasil 9, Gardasil |
| Amag Pharmaceuticals, INC. | $79.66 | 2019 | |
| Pfizer INC. | $69.45 | 2019-2024 | |
| Baxter Healthcare | $66.32 | 2019-2025 | Perclot |
| Exeltis, USA INC. | $65.59 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $59.89 | 2021 | |
| Therapeuticsmd, INC. | $55.81 | 2019 | |
| Myovant Sciences INC. | $50.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.61 | 2025 | |
| Duchesnay USA Incorporated | $46.17 | 2019 | |
| Vertical Pharmaceuticals, LLC | $38.52 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $37.86 | 2024-2025 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $36.99 | 2021 | |
| Allergan, INC. | $32.91 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $28.29 | 2019 | |
| Intercept Pharmaceuticals, INC. | $26.63 | 2023 | Ocaliva |
| Conmed Corporation | $20.84 | 2023 | Airseal |
| Tersera Therapeutics LLC | $20.21 | 2022 | |
| Organon LLC | $18.87 | 2021 | |
| Agile Therapeutics, INC. | $17.89 | 2022 | |
| Shield Therapeutics INC | $17.58 | 2024 | |
| Lupin INC. | $15.35 | 2019 | |
| Avion Pharmaceuticals | $11.74 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.25 | 2021 | |
| Boston Scientific Corporation | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.